Latest News

A current evaluation of seven population-based studies in Germany reveals that blood pressure in Germany has decreased in the last two decades. The greatest decrease was seen in 55 to 74 year-olds. Despite the decrease, blood pressure in Germany is still too high. Particularly...

The molecule microRNA-210 stabilises deposits in the carotid artery and can thus prevent them from tearing, and prevent dangerous blood clots from forming. This is what scientists headed by Prof. Lars Mägdefessel, Professor of Vascular Biology at the Technical University of...

A new clinical study is starting at the German Centre for Cardiovascular Research (DZHK) with an innovative and highly specific blood thinner. Headed by the DZHK Munich site, the scientists want to ascertain how safely and effectively this compound, which only acts locally, can...

Noninvasive perfusion imaging is equivalent to invasive angiography in patients with stable chest pain

A new clinical study of the German Centre for Cardiovascular Research (DZHK) is examining whether an ultrasound evaluation of the inferior vena cava in acute decompensated heart failure (ADHF) with congestion can be implemented in hospitals’ everyday routine and also be conducted...

Contrary to what was previously assumed, physical exercise does not lead to harmful ventricular enlargement. Researchers at the Technical University of Munich (TUM) and the Norwegian University of Science and Technology in Trondheim (NTNU) have disproved this earlier hypothesis...

An international team of scientists, in which researchers of the German Centre for Cardiovascular Research (DZHK) were significantly involved, discovered that nearly half of all hereditary risk factors of a coronary artery disease are also associated with entirely different...

Scientists from the hospital Klinikum rechts der Isar of TU Munich have discovered that endurance and strength training following a heart valve replacement not only improves the patients’ physical fitness, but also their quality of life.

Patients with atrial fibrillation who are treated with oral thrombin inhibitors (OTIs) have a slightly higher risk of suffering a heart attack than patients who take vitamin K antagonists. Scientists headed by Dr. Tobias Petzold of the German Centre for Cardiovascular Research...

Scientists from the Max-Planck-Institute for Dynamics and Self-Organization, as well as from the German Center for Heart and Circulatory Research, have found a new mechanism which leads to atrial fibrillation and even sudden cardiac death due to cardiac arrhythmia.